The evaluation of radiation dose in positron emission tomography (PET) is an essential component of modern nuclear medicine. Accurate dosimetric assessment ensures that the diagnostic benefits of PET ...

DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis PURPOSE: To assess the ability ...

A more accurate way to scan for tuberculosis (TB) has been developed, using positron emission tomography (PET). The team has developed a new radiotracer, which is taken up by live TB bacteria in the ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

Before you take that walk or ride a bike, think again--especially if you will be undergoing a positron emission tomography (PET) scan any time soon. "Any type of physical activity--from tapping your ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that ...